Senators Urge FDA to Withdraw NDI Draft Guidance: Encouraging News for the Supplement Industry
In what may be considered highly encouraging and promising news for the supplement industry, Senators Orrin Hatch (R-UT) and Tom Harkin (D-Iowa) have asked FDA Commissioner